No trading signal. Monitor future Form 4 filings for any open-market purchases or sales by Scully, which would provide insight into insider sentiment.
PRTA drugs
PRTA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 15 $9.76entry
- T+1 · 6mo ago −1.74%α −1.68% · $9.59
- T+5 · 6mo ago +0.72%α −0.25% · $9.83
- T+20 · 5mo ago −16.50%α −18.61% · $8.15
- T+60 · 3mo ago −5.53%α −10.05% · $9.22
Price Chart
How similar events traded
Executive Summary
William P. Scully filed a Form 3 initial statement of beneficial ownership, disclosing 736,000 ordinary shares held directly, 80,000 shares held by Manatee Equity Fund LLC, and 52,000 shares held by spouse. This is a routine administrative filing triggered by Scully's appointment as a director or officer, with no material financial impact.
Key Facts
- William P. Scully filed Form 3 initial statement of beneficial ownership on 2026-05-14, reporting period 2026-05-07.
- Direct holdings: 736,000 ordinary shares.
- Indirect holdings: 80,000 shares via Manatee Equity Fund LLC, 52,000 shares via spouse.
- Power of Attorney executed 2025-09-04 appointing Reid E. Buchanan, Diana L. Hayes, and Todd W. Fennell as attorneys-in-fact for SEC filings.
Financial Impact
No financial impact; Form 3 is a routine initial ownership disclosure.
Risk Factors
- None from this filing; insider selling via Form 4 in the future could signal bearish sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001045463-26-000003 |
| Document: 0001045463-26-000003-index-headers.html | 0001045463-26-000003 |
| Document: 0001045463-26-000003-index.html | 0001045463-26-000003 |
| Document: 0001045463-26-000003.txt | 0001045463-26-000003 |
Track record
20 reports on PRTA
8 of 12 bullish or bearish reports moved the stock their way by T+1. Best: +14.11% at T+60 after the Jun 12, 2026 report. 9 of 12 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $8.16 to $7.97 Now $7.97 −2.33% ▼ −2.33% −0.42% vs SPY
- Nov 10, 20266d ago Insider Buy Bullish 5/10 Entry $8.56 to $8.73 Now $7.97 −6.89% ▲ +1.99% +0.67% vs SPY
- Nov 5, 202611d ago 8-K Neutral 4/10 Entry $7.97 to $8.78 Now $7.97 −0.00% ▲ +10.10% +7.73% vs SPY
- Oct 29, 202618d ago 8-K Bearish 6/10 Entry $8.47 to $8.29 Now $7.97 +5.90% ▲ +2.13% +1.65% vs SPY
- Oct 26, 202621d ago Insider Buy Bullish 5/10 Entry $8.81 to $9.10 Now $7.97 −9.53% ▲ +3.29% +2.95% vs SPY
- Oct 15, 20264w ago Insider Buy Bullish 5/10 Entry $8.35 to $8.48 Now $7.97 −4.55% ▲ +1.56% +1.13% vs SPY
- Sep 30, 20266w ago Insider Buy Bullish 5/10 Entry $8.54 to $8.36 Now $7.97 −6.67% ▼ −2.11% −2.85% vs SPY
- Sep 29, 20266w ago Insider Buy Bullish 5/10 Entry $8.38 to $8.54 Now $7.97 −4.89% ▲ +1.91% +1.73% vs SPY
- Sep 21, 20268w ago Insider Buy Bullish 6/10 Entry $8.99 to $8.68 Now $7.97 −11.35% ▼ −3.45% −2.73% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers